Benperidol is a small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated in psychosis and has 4 investigational indications. Its therapeutic use is listed as antipsychotics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Anquil and Frenactil. Its PubChem CID is 16363.
Benperidol
| CAS No | 2062-84-2 |
|---|---|
| Molecular Formula | C22H24FN3O2 |
| Molecular Weight | 381.4 g/mol |
| Synonyms | 3-[1-[4-(4-fluorophenyl)-4-oxobutyl]piperidin-4-yl]-1H-benzimidazol-2-one |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Benperidol is a small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated in psychosis and has 4 investigational indications.
The listed CAS number is 2062-84-2.
The listed molecular formula is C22H24FN3O2.
The listed molecular weight is 381.4 g/mol.
3-[1-[4-(4-fluorophenyl)-4-oxobutyl]piperidin-4-yl]-1H-benzimidazol-2-one.
The source lists Anquil and Frenactil.